BIOMAT Database Logo BIOMAT Database Logo

Efficacy of Nitric Oxide Administration During Neonatal Cardiopulmonary Bypass. 2020

Christoph P Hornik
Duke Clinical Research Institute, Duke University, Durham, NC, USA.

This editorial accompanies an original research article by Dr Elzein and colleagues describing findings of a randomized, placebo-controlled trial of nitric oxide administration during cardiopulmonary bypass surgery in infants undergoing the Norwood procedure.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D058327 Norwood Procedures A set of surgical procedures performed to establish sufficient outflow to the systemic circulation in individuals with univentricular congenital heart malformations, such as HYPOPLASTIC LEFT HEART SYNDROME, and MITRAL VALVE atresia, associated with systemic outflow obstruction. Follow-on surgeries may be performed and consist of a HEMI-FONTAN PROCEDURE as the stage 2 Norwood procedure and a FONTAN PROCEDURE as the stage 3 Norwood procedure. Norwood Procedure,Norwood Operation,Norwood Procedure, Stage 1,Norwood Procedure, Stage I,Stage 1 Norwood Procedure,Stage I Norwood Procedure,Norwood Operations,Operation, Norwood,Operations, Norwood,Procedure, Norwood,Procedures, Norwood

Related Publications

Christoph P Hornik
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass.
July 2020, World journal for pediatric & congenital heart surgery,
Christoph P Hornik
Nitric oxide formation during cardiopulmonary bypass.
April 1994, The Annals of thoracic surgery,
Christoph P Hornik
Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial.
November 2016, Intensive care medicine,
Christoph P Hornik
Nitric oxide mediates fluid accumulation during cardiopulmonary bypass.
July 1996, The Journal of thoracic and cardiovascular surgery,
Christoph P Hornik
Direct measurement of nitric oxide during experimental cardiopulmonary bypass.
January 2005, The Journal of international medical research,
Christoph P Hornik
Production of nitric oxide during surgery involving cardiopulmonary bypass.
February 1998, Critical care medicine,
Christoph P Hornik
Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass.
January 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Christoph P Hornik
Nitric oxide: platelet protectant properties during cardiopulmonary bypass/ECMO.
June 2002, The journal of extra-corporeal technology,
Christoph P Hornik
Commentary: Encouraging findings for the renal-protective effect of nitric oxide administration during cardiopulmonary bypass.
November 2023, The Journal of thoracic and cardiovascular surgery,
Christoph P Hornik
Inhaled nitric oxide results in deteriorating hemodynamics when administered during cardiopulmonary bypass in neonatal swine.
March 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
Copied contents to your clipboard!